William A. Hawkins's most recent trade in Mimedx Group Inc was a trade of 28,609 Common Stock done at an average price of $6.5 . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 6.47 per share. | 18 Jun 2025 | 28,609 | 204,018 (0%) | 0% | 6.5 | 185,100 | Common Stock |
| Biogen | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 2,370 | 8,860 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jun 2025 | 39,789 | 39,789 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 257,851 (1%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Jun 2025 | 26,493 | 0 | - | - | Restricted Stock Units | |
| Biogen | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2024 | 1,340 | 6,490 (0%) | 0% | 0 | Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 26,493 | 26,493 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2024 | 30,400 | 231,358 (0%) | 0% | 0 | Class A Common Stock | |
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 7.26 per share. | 05 Jun 2024 | 23,190 | 175,409 (0%) | 0% | 7.3 | 168,359 | Common Stock |
| Biogen | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2023 | 960 | 5,150 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 4.95 per share. | 13 Jun 2023 | 35,354 | 152,219 (0%) | 0% | 4.9 | 175,002 | Common Stock |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 30,400 | 30,400 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 200,958 (0%) | 0% | 0 | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jun 2023 | 16,648 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Purchase of securities on an exchange or from another person at price $ 2.66 per share. | 24 May 2023 | 44,000 | 184,310 (0%) | 0% | 2.7 | 117,176 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Purchase of securities on an exchange or from another person at price $ 2.69 per share. | 24 May 2023 | 44,000 | 140,310 (0%) | 0% | 2.7 | 118,391 | Class A Common Stock |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2022 | 16,648 | 16,648 | - | - | Restricted Stock Units | |
| Biogen | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 1,370 | 4,190 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 3.96 per share. | 07 Jun 2022 | 44,191 | 116,865 (0%) | 0% | 4.0 | 174,996 | Common Stock |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 40,573 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 40,573 | 92,361 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 3,949 | 96,310 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Mar 2022 | 3,949 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 3,949 | 3,949 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 13,500 | 0 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 13,500 | 51,788 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 38,288 | 38,288 (0%) | 0% | - | Class A Common Stock | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 10 Feb 2022 | 38,288 | 0 | - | - | Phantom Profit Units | |
| Biogen | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 775 | 2,820 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 10.26 per share. | 27 May 2021 | 17,056 | 72,674 (0%) | 0% | 10.3 | 174,995 | Common Stock |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 40,573 | 40,573 | - | - | Restricted Stock Units | |
| Bioventus Inc - Ordinary S... | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2021 | 13,500 | 13,500 | - | - | Restricted Stock Units | |
| Avanos Medical Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 4,005 | 31,197 (0%) | 0% | 0 | Common Stock | |
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 7.83 per share. | 16 Dec 2020 | 15,964 | 55,618 (0%) | 0% | 7.8 | 124,998 | Common Stock |
| Mimedx Group Inc | William A. Hawkins | Director | Grant, award, or other acquisition of securities at price $ 6.67 per share. | 02 Oct 2020 | 26,236 | 39,654 (0%) | 0% | 6.7 | 174,994 | Common Stock |